Stockreport

Mizuho Initiates Erasca (ERAS) With ‘Outperform' Rating and $16 PT [Yahoo! Finance]

Erasca, Inc.  (ERAS) 
PDF This week, Erasca, Inc. (NASDAQ:ERAS) received strong analyst support amid progress in its RAS inhibitor portfolio. On January 27, 2026, Mizuho initiated coverage of [Read more]